HALOBETASOL MARKET

INTRODUCTION

When certain skin disorders are present, halo beta sol topical is used to reduce any redness, itching, swelling, or other pain. Plaque psoriasis can also be treated with it. The drug in question is a corticosteroid (cortisone-like medicine or steroid).

Only a doctor's prescription is required to purchase this medication. An extremely potent steroid drug called halo beta sol (Ultra vate) is applied to the skin to reduce swelling and irritation brought on by specific skin diseases. Adults and children who are at least 12 years old— Apply to the skin's afflicted region twice daily for up to two weeks. Children under the age of 12 should not use this.

Halo beta sol is a member of the corticosteroid family. Prostaglandins are chemical messengers that cause the affected area to become red, bloated, and itching. It prevents their formation.

HALOBETASOL MARKET SIZE AND FORECAST

The Global HALOBETASOL market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

HALOBETASOL MARKET NEW PRODUCT LAUNCH

In the US, Mayne Pharma introduces Legette (TM) (halo beta sol propionate) foam 0.05%. A new formulation of halo beta sol, a strong topical corticosteroid intended for the treatment of plaque psoriasis in adult patients, is known as LEXETTE. It is a conditionally permitted trade name for halo beta sol foam.

THE US FOOD AND DRUG ADMINISTRATION APPROVED LEXETTE (FDA) Psoriasis patients will have new treatment options thanks to the sophisticated foam composition LEXETTE. Dermatologists value the foam delivery platform's reputation for ease of use, lack of greasiness, and stickiness, especially in hair-bearing areas and under garments.

The psoriasis-focused sales staff that now supports LEXETTE will now be able to offer a strong steroid coupled with steroid-free SORILUX® Foam, both of which are frequently used in Protocols for treating psoriasis. 

Among the more than 60 products that Mayne Pharma sells directly in the US are four branded dermatology products: FABIOR® (tazarotene) Foam, SORILUX (calcipotriene) Foam, DORYX® MPC (doxycycline hyalite) delayed-release tablets, and LEXETTE (halo beta sol propionate) Foam.

Tolsura TM (SUBA®-itraconazole) pills, which the company just launched and for which it recently acquired approval, are used to treat specific fungal infections. A specialist pharmaceutical firm with an ASX listing, Mayne Pharma is committed to using its knowledge of drug delivery to market both branded and generic medications.

More than 100 companies worldwide get contract manufacturing and development services from Mayne Pharma.

HALOBETASOL MARKET COMPANY PROFILE

• Mayne Pharma
• Bausch
• Bryhali
• NCBI
• Teligent Inc.

THIS HALOBETASOL MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many HALOBETASOL are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global  HALOBETASOL and key vendor selection criteria
3. Where is the HALOBETASOL manufactured? What is the average margin per unit?
4. Market share of Global  HALOBETASOL market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global HALOBETASOL in-house
6. key predictions for next 5 years in Global HALOBETASOL market
7. Average B-2-B HALOBETASOL market price in all segments
8. Latest trends in HALOBETASOL market, by every market segment
9. The market size (both volume and value) of the HALOBETASOL market in 2024-2030 and every year in between?
10. Production breakup of HALOBETASOL market, by suppliers and their OEM relationship